Roustit Matthieu

22PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomicsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 11, 2026
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.

|Aug 13, 2026
Redefining Regulatory Proof: The End of the Two-Trial Paradigm.

|Apr 22, 2026
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

|Nov 20, 2025
Drug-Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database.

Alex Hlavaty, Loubna Dari, Jean-Luc Cracowski

|Oct 23, 2025
Development of a self-administered questionnaire to identify levers and barriers to adherence to medication regimens for chronic disease: The QUILAM project.

Audrey Lehmann, Carine Meslot, Matthieu Roustit

|Mar 03, 2025
Electronic pharmaceutical record for best possible medication history at preoperative evaluation to prevent postoperative adverse events: a quasi-experimental study.

Claire Chapuis, Jean-Luc Bosson, Jean-Didier Bardet

Pageof 4

Frequent Collaborators

9 joint publications

Khouri Charles

2 joint publications

Bruno Revol

2 joint publications

Elodie Gautier-Veyret

2 joint publications

Jean-Luc Cracowski